Viewing Study NCT00162305


Ignite Creation Date: 2025-12-25 @ 3:24 AM
Ignite Modification Date: 2025-12-26 @ 2:03 AM
Study NCT ID: NCT00162305
Status: COMPLETED
Last Update Posted: 2016-10-27
First Post: 2005-09-09
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Phase IIA Study of BMS-512148 to Assess Safety, Exposure, and Biological Effects in Stable Type 2 Diabetic Subjects
Sponsor: AstraZeneca
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module